Presentation

The Genomics and Biomedicine research group (GXB) at the University of Vigo is a multidisciplinary team equipped to tackle ambitious new challenges in biomedical and genomic research.

GXB is currently coordinated by David Posada and includes principal investigators Diana Valverde, Carmen Rodríguez, Miguel Arenas, Iria Fernández-Silva, and María Mayán, along with multiple postdoctoral researchers, graduate students, and technical staff.

Our group is part of the Center for Nanomaterials and Biomedicine (CINBIO) at the University of Vigo, a Singular Research Center recognized by the Galician Government.

Our research is funded by the University of Vigo, the Consellería de Cultura, Educación e Ordenación Universitaria of the Galician Government, the Ministerio de Ciencia, Innovación y Universidades of the Spanish Government, and the European Union.

Research

The Genomics and Biomedicine Group (GXB) works in three main research areas:

  1. Genomics of diseases and pathogens
  2. Molecular biology applied to biomedicine
  3. Nanomaterials in biomedicine

In genomics of diseases and pathogens, GXB participates in projects on cancer genomics (including tumor dynamics, circulating tumor cells, and liquid biopsy), pathogen virus genomics (e.g., HIV‑1, SARS‑CoV‑2), and evolutionary genomics, with national and European funding and collaborations with hospitals and research institutes.

In molecular biology applied to biomedicine, GXB investigates the genetic basis of human diseases (e.g., ciliopathies, pulmonary arterial hypertension) and mechanisms underlying aging and disease progression (e.g., cancer, osteoarthritis), with lines focused on biomarkers and therapeutic targets.

In nanomaterials for biomedicine, GXB designs biomedical nanomaterials using green chemistry principles for antitumor and anti‑infective applications and develops delivery systems for therapies, including mRNA delivery for cancer treatment.

Together, GXB combines genomic, experimental, and nanomedicine approaches to advance diagnosis, therapeutics, and clinical translation.

People

Principal investigators

Postdoctoral researchers

  • Joao Alves (mail)
  • Nuria Estévez (mail)
  • Noelia González-Ballesteros (mail)
  • Loretta de Chiara (mail)
  • Valeria Zoni (mail)
  • Carlos López-Solarat (mail)
  • Laura Tomás (mail)
  • Kylie Chen (mail)
  • Luis Daniel González (mail)
  • Adrián Cordido (mail)
  • Soumadipta Mazumdar (mail)

PhD students

  • Sarai Moledo (mail)
  • Laura Ceide (mail)
  • Alfonso Bravo (mail)
  • Sara Vila (mail)
  • Elena Pazos (mail)
  • Paula Iglesias (mail)
  • Alexander Carneiro (mail)
  • Iñaki López (mail)
  • Rebeca Martínez (mail)
  • Anxo Nogueira (mail)
  • Ana Fernández

Staff

  • Merchi Rodríguez (mail)
  • Francesco di Martino (mail)
  • Pablo Barbeito
  • Agatha Carretero

Contact

Our labs can be found in three close locations at the As Lagoas-Marcosende campus of the University of Vigo:

  • School of Biology
    • Diana Valverde
    • Carlos López-Solarat
  • School of Chemistry
    • Carmen Rodríguez-Argüelles
  • CACTI Tower (entrance through CINBIO)
    • Miguel Arenas
    • Valeria Zoni
    • Iria Fernández-Silva
    • David Posada

Phone: (+34) 986 130050
Email: xb5lab@gmail.com

News

We are hiring a lab tech!

We are looking for a full-time laboratory technician. Offer 1023-109593 (in Spanish and English) at https://secretaria.uvigo.gal/uv/web/convocatoria/public/show/1150. Open until June 6. Let’s work together!

phylogenetic origins of relapse using single-cell data

Our phylogenetic analysis of single cells exposes how, where and when malignant cells survive treatment in a personalized manner in a liver relapse of a CRC metastasis. We show that the relapse originated from the expansion of a single metastatic lineage that slowly evolved in the liver. Interestingly, there is a clear contribution of chemotherapy …